Anne‐Sophie Casagrande

Statistics

Publications

Citations

154

H-Index

Active since

2014

Affiliations

Laboratoire COBRA(Current)

Institut National des Sciences Appliquées Rouen Normandie

Centre National de la Recherche Scientifique

Université de Rouen Normandie

Normandie Université

Anne‐Sophie Casagrande is an author at Laboratoire COBRA specializing in tyrosine kinase inhibitors, amyloid beta aggregation, and binding mode analysis.

Publications per year

2014–2016

Publications

A novel DYRK1A (Dual specificity tyrosine phosphorylation‐regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies <i>in vitro</i>

Séverine Coutadeur, Hélène Benyamine, Laurence Delalonde et al. · Journal of Neurochemistry · 2014 · 111 citations

Life Sciences, Molecular Biology, Neuroscience +17

An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-<i>f</i>] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases

A. Chaikuad, Julien Diharce, Martin Schröder et al. · Journal of Medicinal Chemistry · 2016 · 43 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–2 of 2